Figure 3From: Hierarchical cluster analysis of immunophenotype classify AML patients with NPM1 gene mutation into two groups with distinct prognosis Kaplan-Meier survival curves of relapse-free survival (left) of all 130 NPM1- mutated patients stratified by immunophenotypic clustering profile and FLT3 ITD mutation. (p < 0.001). Kaplan-Meier survival curves of overall survival (right) of all 130 NPM1- mutated patients stratified by immunophenotypic clustering profile and FLT3 ITD mutation. (p = 0.017).Back to article page